Optibiotix Health Share Discussion Threads

[lukead] 20/10/2016 13:38

well done Judi

[lukead] 20/10/2016 13:37

just filter me, easy peasy, sure you don't look at the other thread lol

PS, predictably, he has responded to that post, Griffin will learn (hopefully)

[michaelmouse] 20/10/2016 13:29

In short, the company is lending money to itself.

Bloody Hell!

Awful!!

[elrico] 20/10/2016 13:27

I couldn't resist. I added a few more today.....to my filter list :-)


opodio20 Oct '16 - 10:50 - 16520 of 16538 0 0 (Filtered) troll
lukead20 Oct '16 - 09:54 - 16515 of 16538 3 0 (Filtered) underage
larva20 Oct '16 - 09:44 - 16510 of 16538 0 0 (Filtered) troll

[michaelmouse] 20/10/2016 13:23

griffin81 - Yes upon re-reading the RNS they have indeed used their own cash using a convertible loan.

However, this just makes it far worse in my opinion.

Investors should consider why the company didn't just give the company £400k from it's cash pile? After all, at the moment, it's one and the same company.

Financial Engineering at its very worst.

Essentially the parent company is lending money to it's intended "spin-off" which doesn't generate any revenues. In fact the whole company generates little revenue.

If they get the IPO away then the convertible loan notes will convert into shares and the parent company has the option to get its cash back by selling their shares in SkinBiotix. I'd guess the conversion price will have been set well below the intended IPO price?

Clearly not illegal and some might even say clever or de-risking the parent?

Others might say it's very murky at best.

Bargepole. I wouldn't invest £5 never mind £50,000.

[john henry] 20/10/2016 13:17

7.5k @ 66.2p. 1.5k @ 67.4p 20k @ 67p by or sell. Earlier 25k @ 67p buy or sell.

[john henry] 20/10/2016 12:50

Well I guess the gap up from th Midas tip was bound to be filled with no decent follow up news.

[monkeywench1] 20/10/2016 12:40

lol such a lady.

[griffin81] 20/10/2016 12:36

MichaelMouse, regarding your comment questioning why OptiBiotix has raised £400k if it is fully funded, you have misunderstood the RNS.

OptiBiotix has invested its own cash into SkinBiotix using a convertible loan, this provides the new division / future listing with the funding required to 'complete the development and human studies for its first product application. SkinBiotix also will use the funds to support an initial public offering.'

At this stage this isn't new cash, it is essentially a reallocation of Group funds internally, however it is required for disclosure because of the intent to spin off the Skin division.

As a recent investor in OptiBiotix, (I built up a £50k position in August), one of the attractions for me to invest was the intention by the company to split off different divisions, each with different funding requirements, investment horizons and expected valuations. Significant progress has been made since then in appointing the right broker, leadership in the new division and allocation of funds. I view the IPO in this division as a key milestone and the action from the company in gearing up for this over the last month is clear indication they intend to create this listing in the near term.

[riskybusiness1] 20/10/2016 12:15

But it is hard for the market to realise the true value. The reason behind this is because of the great difference in the area in which each company will operate. Skin = biotherapeutics Where as opti targets the food and wellbeing markets. These are totally different. Some investors may be interested and want to invest in skin yet be wary of optis broad divisions. One of the main reasons to spin out a company from its parent co is to create more of a focus. This focus in theory will help development and to realise true valuation within its sector. Skin has the potential to be massive.Think people forget we're on aim. Opti started at 8p from a single idea. Proof of concept human trials etc which derisks the technology will unlock great value for shareholders in a short space of time. It is the next leg up which takes time which is where opti are currently now. Getting these revenue making deals across the line takes the time especially good deals.

[lukead] 20/10/2016 12:15

He will be copying that one now, you dope lol

[lukead] 20/10/2016 12:00

i note the clown is watching this site avidly and is rather taken with Judi's inane postings, so much so that he copies them onto his thread, how sweet.

[jimbobjames2002] 20/10/2016 11:39

Simply put the problem is uncertainty. There is so much to like about OPTI but investors need more meat on the bone. Until we know more specific details about the IPO and any 'deals' that may be in the pipeline that uncertainty will remain. I seriously hope SOH knows that he MUST announce some meaningful revenue related news before the IPO, otherwise what's to stop it disappointing?

So many IPOs tank so there needs to be a more concrete footing for OPTI/Skinbiotix before we reach that stage. It's no good having world changing products if you can't communicate and demonstrate it's profitability. Investors want to see something tangible.

Don't get me wrong, I'm still long term very bullish, but patience is certainly a virtue where OPTIs concerned.

[michaelmouse] 20/10/2016 11:28

"Cavalry slowly appearing :)"

I think you'll find they're totally surrounded by Indians!

[judijudi] 20/10/2016 11:25

Cavalry slowly appearing :)

[michaelmouse] 20/10/2016 11:09

CURRYPASTY - "just got 10k, does that count?"

Probably get as many as you want at the moment.

Selling any though will be a different matter.

[monkeywench1] 20/10/2016 11:08

Didn't need a chartist to predict this. Just common sense.

[michaelmouse] 20/10/2016 11:06

judijudi - "Didnt see any chartist predicting this"

Errrhhhhhmmmmmm!

Perfect rolling top and has been for some time, you don't need to be a chartist to see it!

[john henry] 20/10/2016 11:06

Spot on mouse20 and that news hasn't materialised.

[currypasty] 20/10/2016 11:03

just got 10k, does that count?